New Congress To Tackle Burning Health Care Issues, Including Drug Prices
KHN’s Sarah Jane Tribble discusses the twists and turns with CBS News.
Cost and Quality
781 - 800 of 3,362 Results
-
-
Measure To Cap Dialysis Profits Pummeled After Record Spending By Industry
The dialysis industry raised nearly $111 million in a successful bid to defeat the measure, which also was opposed by hospitals and doctors. The union that sponsored the measure collected about one-sixth that amount.
By Ana B. Ibarra and Anna Gorman -
House Dems In New Seats Of Power Will Steer Health Policy, Attack Drug Prices
Democrats, who have a history of championing the Affordable Care Act and railing about drug prices, will now chair several house committees.
-
Beyond The Buzz: What Do Americans Mean By ‘Medicare-For-All’?
KHN's news analysis on "Medicare-for-all" sparks a broader conversation.
-
Ad Check: What Happens If California Limits Dialysis Center Profits?
Both sides in the contentious and expensive battle over California’s Proposition 8 are cherry-picking the facts ahead of Tuesday’s vote as dialysis companies spend record amounts to persuade voters through ads.
-
Podcast: KHN’s ‘What The Health?’ Open Enrollment And A Midterm Preview
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Margot Sanger-Katz of The New York Times, Anna Edney of Bloomberg News and Joanne Kenen of Politico discuss the start of open enrollment for individual health insurance plans for 2019 and preview what next week’s midterm elections might mean for health policy. Plus, Barbara Feder Ostrov of KHN and California Healthline talks to Julie about the latest NPR-KHN “Bill of the Month” feature.
-
Billions In ‘Questionable Payments’ Went To California’s Medicaid Insurers And Providers
The money was paid on behalf of more than 400,000 people who may have been ineligible for the public program, a state audit found. One had been dead for four years before payments stopped.
By Chad Terhune -
Pricey Precision Medicine Often Financially Toxic For Cancer Patients
Medical treatments targeting the DNA in tumor cells are celebrated, but insurers often won’t cover the skyrocketing cost.
By Liz Szabo -
That’s A Lot Of Scratch: The $48,329 Allergy Test
A California college professor never imagined that trying to figure out what was causing her rash could add up to such a huge bill.
-
In California, Novel Initiatives Test Cities’ Power — And Will — To Tame Health Costs
Union-backed initiatives in Palo Alto and Livermore, Calif., aim to cap charges by hospitals and doctors, seeking to build on national furor over rising medical bills. The measures arise in health care markets that are among the most expensive in the nation.
By Rob Waters -
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
-
Trump Adds A Global Pricing Plan To Wide Attack On Drug Prices, But Doubts Persist
Over the past five months, the Trump administration has proposed a series of reforms to lower the cost of prescription drugs.
-
Readers And Tweeters: Are Millennials Killing The Primary Care Doctor?
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
-
Podcast: KHN’s ‘What The Health?’ Trump, GOP Fight Back On Health Care
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Anna Edney of Bloomberg News, Kimberly Leonard of the Washington Examiner and Alice Ollstein of Politico discuss a flurry of proposals from the Trump administration on prices Medicare pays for drugs and the Affordable Care Act.
-
Spending Against Dialysis Ballot Measure In California Breaks Record
Dialysis companies have contributed more than $110 million to defeat an initiative on California’s Nov. 6 ballot that would limit their profits — breaking the $109 million record set by the pharmaceutical industry in 2016.
-
Fixing Obamacare’s ‘Family Glitch’ Hinges On Outcome Of November Elections
This gap in the 2010 health law means health insurance remains unaffordable for millions of Americans. For now, relief is hard to come by.
-
News Analysis
Politicians Hop Aboard ‘Medicare-For-All’ Train, Destination Unknown
Candidates are charging toward midterm elections on a platform of single-payer and universal coverage rhetoric. Yet “Medicare-for-all” and single-payer mean different things to different people.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
-
Children’s Hospitals Again Cry For Help From Voters. But Are They Really Hurting?
California’s 13 children’s hospitals are asking voters in November to approve $1.5 billion in bonds to help them pay for construction and equipment, the third such measure in 14 years. Some health care experts and election analysts believe the repeated financial requests aren’t justified.
-
SIMPLE SURGERIES. TRAGIC RESULTS.
Influential Leapfrog Group Jumps In To Rate 5,600 Surgery Centers
In the wake of a KHN/USA Today Network investigation, Leapfrog will check the safety and quality of outpatient centers.